ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients.

Authors
Category Primary study
JournalCANCER RESEARCH
Year 2012
This article has no abstract
Epistemonikos ID: 2d71e02cafa0680a32895d9534737c1d2145f620
First added on: Feb 05, 2025